Crossref
Analysis of the Prognostic Outcomes and Influencing Factors of Levetiracetam Monotherapy in Patients with Epilepsy
Advances in Clinical Medicine · 2026 · 16 (06) · 338-346
DOI: 10.12677/acm.2026.1662226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 嘉旭 王. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
王, 嘉. (2026). Analysis of the Prognostic Outcomes and Influencing Factors of Levetiracetam Monotherapy in Patients with Epilepsy. Advances in Clinical Medicine, 16(06), 338-346. https://doi.org/10.12677/acm.2026.1662226
Vancouver
王 嘉. Analysis of the Prognostic Outcomes and Influencing Factors of Levetiracetam Monotherapy in Patients with Epilepsy. Advances in Clinical Medicine. 2026;16(06):338-346. doi:10.12677/acm.2026.1662226
BibTeX
@article{2026,
author = {王, 嘉旭},
title = {Analysis of the Prognostic Outcomes and Influencing Factors of Levetiracetam Monotherapy in Patients with Epilepsy},
journal = {Advances in Clinical Medicine},
year = {2026},
volume = {16},
number = {06},
pages = {338--346},
doi = {10.12677/acm.2026.1662226}
}
EUVIMED